|
CN111253434A
|
|
Preparation method of dipalmitoyl phosphatidic acid
|
|
CN111454289A
|
|
Preparation method of dioleoyl phosphatidylcholine
|
|
CN110818706A
|
|
Four-condensed ring quinoxaline derivative and preparation method thereof
|
|
CN108586250A
|
|
A kind of sodium stearyl fumarate auxiliary material and preparation method thereof
|
|
CN108689876A
|
|
A kind of preparation method of 8- (2-Hydroxylbenzamide base) Sodium Caprylate
|
|
CN107987082A
|
|
A kind of Preparation Method And Their Intermediate of Larotrectinib
|
|
CN107721989A
|
|
A kind of Preparation Method And Their Intermediate of pazopanib
|
|
CN107827762A
|
|
A kind of (2,3 dioleoyl propyl group) three changes ammonio methacrylate and its production and use
|
|
CN107118207A
|
|
The preparation method of one class CDK inhibitor
|
|
CN105753897A
|
|
Preparation method of synthetic phospholipid DPPC (dipalmitoyl phosphatidylcholine)
|
|
CN105732702A
|
|
Hydrogenated soybean lecithin and preparation method and application thereof
|
|
CN105294759A
|
|
Preparation method of antitumor drug
|
|
CN104817541A
|
|
Synthetic method of anti-tumor medicine
|
|
CN104030959A
|
|
Deuterated hepatitis c virus inhibitor
|
|
CN103864840A
|
|
Preparation method of artificial phospholipid DSPG
|
|
CN103804446A
|
|
Preparation method of 3,5-dibenzoyl-2-deoxy-2-fluoro-2-methyl-D-ribo-gamma-lactone
|
|
CN103664876A
|
|
Quinoline derivative and usage thereof
|
|
CN103539781A
|
|
Method for synthesizing WNT (Wingless Int.) signal path inhibitor
|
|
CN103539789A
|
|
Preparation method of quinazoline derivative as tyrosine kinase inhibitor
|
